missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ ADAM22 Polyclonal Antibody

Description
Recommended positive controls: IMR32. Predicted reactivity: Human (99%), Mouse (83%), Bovine (89%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. This gene is highly expressed in the brain and may function as an integrin ligand in the brain. Alternative splicing results in several transcript variants.
Specifications
Specifications
| Antigen | ADAM22 |
| Applications | Immunohistochemistry (Frozen), Western Blot |
| Classification | Polyclonal |
| Concentration | 0.93 mg/mL |
| Conjugate | Unconjugated |
| Formulation | 0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7 |
| Gene | Adam22 |
| Gene Accession No. | Q9P0K1, Q9R1V6 |
| Gene Alias | 2900022I03Rik; a disintegrin and metallopeptidase domain 22; a disintegrin and metalloprotease domain (ADAM) 22; a disintegrin and metalloprotease domain 22; a disintegrin and metalloproteinase; a disintegrin and metalloproteinase domain 22; ADAM; ADAM 22; ADAM metallopeptidase domain 22; Adam22; ADAMs; AI854032; Disintegrin and metalloproteinase domain-containing protein 22; MDC2; metalloendopeptidases; Metalloproteinase-disintegrin ADAM22-3; metalloproteinase-like, disintegrin-like, and cysteine-rich protein 2; MGC149832 |
| Gene Symbols | Adam22 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?